June 8, 2022
Clinical researchers, seeking to understand the statistical benefits of a common Phase 2 oncology design, now have a...
Read article
June 7, 2022
In most instances of blinded sample size re-estimation, the timing of the interim analysis that determines whether the...
Read article
April 5, 2022
Hello! I’m delighted to pen my inaugural blog post here as Cytel’s Chief Medical Officer. In this series, we’ll explore...
Read article
May 12, 2020
In our previous blog, “Remote Working Arrangement – How to get it right?”, we talked about how the need for social...
Read article
May 5, 2020
Cytel's team of oncology trial design and advanced analytics experts are hosting a series of complimentary webinars...
Read article
April 23, 2020
Cytel is hosting a webinar, “A Clinician’s Perspective on Cancer Drugs Development”, on April 28, 2020. Our speaker,...
Read article
February 28, 2019
In honor of Rare Disease Day 2019 we share a new Cytel podcast featuring Cytel Strategic Consultant Ursula Garczarek...
Read article
January 10, 2019
Nand Kishore Rawat is a Director and Head, Early Phase Biostatistics based in the King of Prussia, PA Cytel office. We...
Read article
December 5, 2018
In this blog, Paul Terrill, Director of Strategic Consulting at Cytel outlines his blueprint for ensuring smooth...
Read article
October 23, 2018
Cytel data scientists apply advanced statistical techniques including predictive modeling of biological processes and...
Read article
September 20, 2018
At Cytel we believe that expert statistical input has the power to shape the future of clinical development: de-risking...
Read article
August 23, 2018
Cytel has grown significantly over the last 30 years, with operations across North America, Europe, and India. All of...
Read article
August 1, 2018
By Gordhan Bagri and Munshi Imran Hossain with H A S Shri Kishore Shiny (from RStudio) is one of the most popular R...
Read article
July 24, 2018
At Cytel our strategic consulting team works on a wide range of projects including: Identifying the best clinical trial...
Read article
July 18, 2018
A recent article published by Cytel authors Samadhan Ghubade, Sharayu Paranjpe, Kushagra Gupta, Anil Gore and colleague...
Read article
March 16, 2018
At Cytel we believe that expert statistical input has the power to shape the future of clinical development: de-risking...
Read article
February 13, 2018
Our strategic consulting team work on projects such as: Identifying the best clinical trial design, implementing...
Read article
May 22, 2017
James (Jim) Bolognese, Senior Director, Strategic Consulting, Clinical Services at Cytel Inc. was named a 2017 fellow...
Read article
January 30, 2017
Single ascending dose (SAD) and multiple ascending dose (MAD) studies are typically the first in human studies. They...
Read article
January 23, 2017
As a group, Cytel had over 40 successful regulatory interactions last year, many of which supported approvals for...
Read article
December 13, 2016
In the complex world of trial design and data analysis biostatisticians and data scientists need to ensure they are...
Read article
December 2, 2016
At a recent Pfizer/ Cytel seminar on rare disease and oncology development, Cytel’s Lingyun Liu presented innovative...
Read article
November 18, 2016
Challenge Our client had the following key questions which they wanted our pharmacometrics group to address for an...
Read article
September 13, 2016
Exposure-response data gained from clinical studies can provide a basis for model-based analysis and simulation,...
Read article
September 9, 2016
Challenge: Our client, an emerging biotechnology company, was preparing for the next stage of development for their...
Read article
February 10, 2015
Cardiovascular outcome trials (CVOTs) have earned the reputation of being the untamable behemoths of the clinical...
Read article
October 14, 2014
We are often asked how statistical consultants can add value to the clinical development process. What do they...
Read article
September 4, 2014
Imagine if we were to count the number of possible reasons that investigators might have for monitoring a biomarker...
Read article
September 2, 2014
As more clinical trials make use of adaptive designs, investors have come to realize that high quality trial designs...
Read article
